| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |